Parkinson’s Disease: Potential Actions of Lithium by Targeting the WNT/β-Catenin Pathway, Oxidative Stress, Inflammation and Glutamatergic Pathway
Parkinson’s disease (PD) is one of the major neurodegenerative diseases (ND) which presents a progressive neurodegeneration characterized by loss of dopamine in the substantia nigra pars compacta. It is well known that oxidative stress, inflammation and glutamatergic pathway play key roles in the de...
Main Authors: | Alexandre Vallée, Jean-Noël Vallée, Yves Lecarpentier |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/10/2/230 |
Similar Items
-
Lithium and Atypical Antipsychotics: The Possible WNT/β Pathway Target in Glaucoma
by: Alexandre Vallée, et al.
Published: (2021-04-01) -
Cannabidiol and the Canonical WNT/β-Catenin Pathway in Glaucoma
by: Alexandre Vallée, et al.
Published: (2021-04-01) -
The Key Role of the WNT/β-Catenin Pathway in Metabolic Reprogramming in Cancers under Normoxic Conditions
by: Alexandre Vallée, et al.
Published: (2021-11-01) -
Opposed Interplay between IDH1 Mutations and the WNT/β-Catenin Pathway: Added Information for Glioma Classification
by: Alexandre Vallée, et al.
Published: (2021-05-01) -
Neuroinflammation in Schizophrenia: The Key Role of the WNT/β-Catenin Pathway
by: Alexandre Vallée
Published: (2022-03-01)